Ocuphire Pharma, Inc. Profile Avatar - Palmy Investing

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily prese…

Biotechnology
US, Farmington Hills [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Ocuphire Pharma, Inc. (OCUP) to it's peer group.

Peer Group
Loading...
End of OCUP's Analysis
CIK: 1228627 CUSIP: 67577R102 LEI: - UEI: -
Secondary Listings
OCUP has no secondary listings inside our databases.